The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy
Open accessAbstract
BACKGROUND.: The objective of the current retrospective study was to compare the epidemiology of candidemia and its risk factors in patients who had hematologic malignancies(HM) with those in patients who had solid tumors (ST). METHODS.: The medical and electronic records of all patients with cancer who had candidemia at the authors' institution from 1993 to 2003 were reviewed for demographic data and clinical information, including the use of prophylactic fluconazole, the infecting Candida species, and the source of candidemia (catheter‐related vs other apparent sources). RESULTS.: Six hundred thirty‐five patients with candidemia were analyzed. C. glabrata and C. krusei were the leading causes of candidemia in 31% and 24% of patients with HM, respectively, and in 18% and 2% of patients with ST, respectively (P < .001). A catheter was the source of candidemia in 36% of the patients with ST and in 12% of the patients with HM (P < .001). Response to antifungal therapy occurred in 73% of the ST group compared with 49% of the HM group (P < .001). Multivariate logistic regression analysis revealed that fluconazole prophylaxis was a risk factor for both C. glabrata and C. krusei candidemia. The analysis also identified neutropenia as a risk factor for all candidemia and catheter‐related infection as a risk factor for C. parapsilosis candidemia. CONCLUSIONS.: The results of this study indicated that C. glabrata and C. krusei were the leading causes of candidemia in patients with HM. Neutropenia was the leading risk factor for all candidemia, whereas the catheter was the leading risk factor for C. parapsilosis candidemia. Cancer 2008. © 2008 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Semiquantitative Culture Method for Identifying Intravenous-Catheter-Related Infection
Maki, D. G., Weise, C. E., & Sarafin, H. W. (1977) · New England Journal of Medicine · doi:10.1056/nejm197706092962301 · Cited by 2,027
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
Cornely, O. A., Maertens, J., Winston, D. J., Perfect, J., Ullmann, A. J., Walsh, T. J., Helfgott, D., Holowiecki, J., Stockelberg, D., Goh, Y.-T., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061094 · Cited by 1,813
Guidelines for the management of intravascular catheter-related infections
Mermel, L. A., Farr, B. M., Sherertz, R. J., Raad, I. I., O'Grady, N., Harris, J. S., & Craven, D. E. (2001) · Clinical Infectious Diseases · doi:10.1086/320001 · Cited by 1,449
Self-citationNosocomial Bloodstream Infections in United States Hospitals: A Three‐Year Analysis
Edmond, M. B., Wallace, S. E., McClish, D. K., Pfaller, M. A., Jones, R. N., & Wenzel, R. P. (1999) · Clinical Infectious Diseases · doi:10.1086/520192 · Cited by 1,387
Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease
Ullmann, A. J., Lipton, J. H., Vesole, D. H., Chandrasekar, P., Langston, A., Tarantolo, S. R., Greinix, H., Morais de Azevedo, W., Reddy, V., Boparai, N., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061098 · Cited by 1,345
Secular Trends in the Epidemiology of Nosocomial Fungal Infections in the United States, 1980-1990
Sague, C. M. B., Jarvis, W. R., & System, N. N. I. S. (1993) · Journal of Infectious Diseases · doi:10.1093/infdis/167.5.1247 · Cited by 1,140
Attributable Mortality of Nosocomial Candidemia, Revisited
Gudlaugsson, O., Gillespie, S., Lee, K., Berg, J. V., Hu, J., Messer, S., Herwaldt, L., Pfaller, M., & Diekema, D. (2003) · Clinical Infectious Diseases · doi:10.1086/378745 · Cited by 1,140
Reference method for broth dilution antifungal susceptibility testing of yeasts : Approved standard
Rex, J. H., & Clinical (2008) · Clinical and Laboratory Standards Institute eBooks · Cited by 1,052
Secular trends in nosocomial primary bloodstream infections in the United States, 1980–1989.
Banerjee, S. N., Emori, T. G., Culver, D. H., Gaynes, R. P., Jarvis, W. R., Horan, T., Edwards, J. R., Tolson, J., Henderson, T., Martone, W. J., et al. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90349-3 · Cited by 880
Pappas, P. G., Rex, J. H., Lee, J., Hamill, R. J., Larsen, R. A., Powderly, W., Kauffman, C. A., Hyslop, N., Mangino, J. E., Chapman, S., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/376906 · Cited by 845
Hospital-Acquired Candidemia: The Attributable Mortality and Excess Length of Stay
Wey, S. B. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.1988.00380120094019 · Cited by 831
Kuhn, D. M., George, T., Chandra, J., Mukherjee, P. K., & Ghannoum, M. A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1773-1780.2002 · Cited by 764
The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance
Hong Nguyen, M., Peacock, J. E., Morris, A. J., Tanner, D. C., Nguyen, M. L., Snydman, D. R., Wagener, M. M., Rinaldi, M. G., & Yu, V. L. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(95)00010-0 · Cited by 758
The Epidemiology of Hematogenous Candidiasis Caused by Different Candida Species
Abi‐Said, D., Anaissie, E., Uzun, O., Raad, I., Pinzcowski, H., & Vartivarian, S. (1997) · Clinical Infectious Diseases · doi:10.1086/513663 · Cited by 755 · cited 1×
“parapsilosis, even in patients with hematologic malignancies.(25) The changing epidemiology observed in this patient population over time is consistent in the comparisons outlined in Table 4.”
ResultSelf-citationNon-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance
Krcmery, V., & Barnes, A. J. (2002) · Journal of Hospital Infection · doi:10.1053/jhin.2001.1151 · Cited by 733
Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality.
Fraser, V. J., Jones, M., Dunkel, J., Storfer, S., Medoff, G., & Dunagan, W. C. (1992) · Clinical Infectious Diseases · doi:10.1093/clind/15.3.414 · Cited by 679
Trick, W. E., Fridkin, S. K., Edwards, J. R., Hajjeh, R. A., Gaynes, R. P., & Hospitals, T. N. N. I. S. S. (2002) · Clinical Infectious Diseases · doi:10.1086/342300 · Cited by 660
Viscoli, C., Girmenia, C., Marinus, A., Collette, L., Martino, P., Vandercam, B., Doyen, C., Lebeau, B., Spence, D., Krcmery, V., et al. (1999) · Clinical Infectious Diseases · doi:10.1086/514731 · Cited by 601
Almirante, B., Rodríguez, D., Park, B. J., Cuenca-Estrella, M., Planes, A. M., Almela, M., Mensa, J., Sanchez, F., Ayats, J., Gimenez, M., et al. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.4.1829-1835.2005 · Cited by 566
Antifungal drug resistance of pathogenic fungi
Kontoyiannis, D. P., & Lewis, R. E. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08162-x · Cited by 553
Self-citationGuideline for Prevention of Intravascular-Device-Related Infections
Pearson, M. L., & The Hospital Infection Control Practices Advisory Committee (1996) · Infection Control and Hospital Epidemiology · doi:10.2307/30141155 · Cited by 531
Kao, A. S., Brandt, M. E., Pruitt, W. R., Conn, L. A., Perkins, B. A., Stephens, D. S., Baughman, W. S., Reingold, A. L., Rothrock, G. A., Pfaller, M. A., et al. (1999) · Clinical Infectious Diseases · doi:10.1086/313450 · Cited by 457
Komshian, S. V., Uwaydah, A. K., Sobel, J. D., & Crane, L. R. (1989) · Clinical Infectious Diseases · doi:10.1093/clinids/11.3.379 · Cited by 457
Wingard, J. R., Merz, W. G., Rinaldi, M. G., Miller, C. B., Karp, J. E., & Saral, R. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.9.1847 · Cited by 340
Pfaller, M. A., & Diekema, D. J. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.10.3551-3557.2002 · Cited by 269
Impact of the changing epidemiology of fungal infections in the 1990s
Pfaller, M., & Wenzel, R. (1992) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01962067 · Cited by 238
MUKHERJEE, P., & CHANDRA, J. (2004) · Drug Resistance Updates · doi:10.1016/j.drup.2004.09.002 · Cited by 222
Bodey, G. P., Mardani, M., Hanna, H. A., Boktour, M., Abbas, J., Girgawy, E., Hachem, R. Y., Kontoyiannis, D. P., & Raad, I. I. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)01130-5 · Cited by 209
Self-citationGuideline for Prevention of Intravascular-Device–Related Infections
Pearson, M. L., & Hospital Infection Control Practices Advisory Committee (1996) · Infection Control & Hospital Epidemiology · doi:10.1086/647338 · Cited by 201
Risk Factors forCandida tropicalisFungemia in Patients with Cancer
Kontoyiannis, D. P., Vaziri, I., Hanna, H. A., Boktour, M. R., Thornby, J. I., Hachem, R. Y., Bodey, G. P., & RAAD, I. I. (2001) · Clinical Infectious Diseases · doi:10.1086/323812 · Cited by 192
Self-citationIncreasing Incidence of Candidemia: Results from a 20-Year Nationwide Study in Iceland
Ásmundsdóttir, L. R., Erlendsdóttir, H., & Gottfredsson, M. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.9.3489-3492.2002 · Cited by 188
Candidiasis: Pathogenesis, Diagnosis and Treatment
Balsdon, M. J. (1993) · Sexually Transmitted Infections · doi:10.1136/sti.69.4.326-b · Cited by 173
Candida krusei Fungemia: An Escalating Serious Infection in Immunocompromised Patients
Abbas, J., Bodey, G. P., Hanna, H. A., Mardani, M., Girgawy, E., Abi-Said, D., Whimbey, E., Hachem, R., & Raad, I. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.17.2659 · Cited by 172
Self-citationCandida biofilms: antifungal resistance and emerging therapeutic options.
Kuhn, D. M., & Ghannoum, M. A. (2004) · PubMed · Cited by 170
Girmenia, C., Martino, P., De Bernardis, F., Gentile, G., Boccanera, M., Monaco, M., Antonucci, G., & Cassone, A. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/23.3.506 · Cited by 164
Candida parapsilosis Characterization in an Outbreak Setting
Kuhn, D. M., Mukherjee, P. K., Clark, T. A., Pujol, C., Chandra, J., Hajjeh, R. A., Warnock, D. W., Soll, D. R., & Ghannoum, M. A. (2004) · Emerging Infectious Diseases · doi:10.3201/eid1006.030873 · Cited by 161
Systemic candidiasis in intensive care units: A multicenter, matched-cohort study
Leleu, G., Aegerter, P., & Guidet, B. (2002) · Journal of Critical Care · doi:10.1053/jcrc.2002.35815 · Cited by 160
White, M. H. (1997) · Clinical Infectious Diseases · doi:10.1086/513661 · Cited by 151 · cited 1×
“krusei.(24,26,29,32,33) Investigators have identified several other risk factors for candidemia over the years, including the use of central venous catheters,”
BackgroundIncreased incidence of fungemia caused by Candida krusei
Merz, W. G., Karp, J. E., Schron, D., & Saral, R. (1986) · Journal of Clinical Microbiology · doi:10.1128/jcm.24.4.581-584.1986 · Cited by 139
Hope, W. W., Morton, A., & Eisen, D. P. (2002) · Journal of Hospital Infection · doi:10.1053/jhin.2001.1131 · Cited by 130
Pittet, D. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.155.11.1177 · Cited by 115
Pittet, D., Safran, E., Harbarth, S., BORST, F., Copin, P., Rohner, P., Scherrer, J.-R., & Auckenthaler, R. (1996) · Infection Control and Hospital Epidemiology · doi:10.2307/30141281 · Cited by 111
Candidosis in the intensive care unit: a 20-year survey
Tortorano, A. M., Caspani, L., Rigoni, A. L., Biraghi, E., Sicignano, A., & Viviani, M. A. (2004) · Journal of Hospital Infection · doi:10.1016/j.jhin.2004.01.017 · Cited by 76
Tuberculosis Infection among Staff at a Canadian Community Hospital
Liss, G. M., Khan, R., Koven, E., et al. (1996) · Infection Control and Hospital Epidemiology · doi:10.2307/30142362 · Cited by 19
Research works printed but not linked: 1
- Pittet D, 1996, Microbiological factors influencing the outcome of nosocomial bloodstream infections, Infect Control Hosp Epidemiol., 17, 29
Cited by
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06506-y · Cited by 5,082
Freifeld, A. G., Bow, E. J., Sepkowitz, K. A., Boeckh, M. J., Ito, J. I., Mullen, C. A., Raad, I. I., Rolston, K. V., Young, J.-A. H., & Wingard, J. R. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir073 · Cited by 3,463
Self-citationSurviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005337 · Cited by 2,935
Epidemiology of Invasive Mycoses in North America
Pfaller, M. A., & Diekema, D. J. (2010) · Critical Reviews in Microbiology · doi:10.3109/10408410903241444 · Cited by 901
Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species
Whaley, S. G., Berkow, E. L., Rybak, J. M., Nishimoto, A. T., Barker, K. S., & Rogers, P. D. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.02173 · Cited by 900
“…able to develop high-level resistance after exposure to azole antifungals (Fidel et al., 1999; Lee et al., 2009) and is one of the most frequent species isolated in breakthrough infections from patients receiving azole prophylaxis (Bennett et al., 2004; Imhof et al., 2004; Hachem et al., 2008).”
Background
Metadata
- Authors
- Hachem, R., Hanna, H., Kontoyiannis, D., Jiang, Y., & Raad, I.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2008-04-15
- Volume
- 112
- Issue
- 11
- Pages
- 2493-2499
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W1979497376
- Cited by
- 331
- References
- 44
- FWCI
- 18.65
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.